Vi vill tacka vår handledare Karin Stensjö samt beställarrepresentant Gunnar Johansson vilka vi haft mest kontakt med under arbetets gång.
Referenser
ACTIP. 2017. Monoclonal Antibodies Approved by the EMA and FDA for Therapeutic Use – ACTIP. WWW-dokument 2017-05-18:
https://www.actip.org/products/monoclonal-antibodies-approved-by-the-ema-and-fda-for-therapeutic-use/. Hämtad 2020-05-28.
Ahmad M, Hirz M, Pichler H, Schwab H. 2014. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Applied
Microbiology and Biotechnology 98: 5301–5317.
Assenberg R, Wan PT, Geisse S, Mayr LM. 2013. Advances in recombinant protein
expression for use in pharmaceutical research. Current Opinion in Structural Biology 23: 393–402.
Baghban R, Farajnia S, Rajabibazl M, Ghasemi Y, Mafi A, Hoseinpoor R, Rahbarnia L, Aria M. 2019. Yeast Expression Systems: Overview and Recent Advances. Molecular Biotechnology 61: 365–384.
Bertani B, Ruiz N. 2018. Function and Biogenesis of Lipopolysaccharides. EcoSal Plus, doi 10.1128/ecosalplus.ESP-0001-2018.
Berting A, Farcet MR, Kreil TR. 2010. Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing.
Biotechnology and Bioengineering 106: 598–607.
Bielser J-M, Wolf M, Souquet J, Broly H, Morbidelli M. 2018. Perfusion mammalian cell culture for recombinant protein manufacturing – A critical review. Biotechnology Advances 36: 1328–1340.
Bracke A, Hoogewijs D, Dewilde S. 2018. Exploring three different expression systems for recombinant expression of globins: Escherichia coli, Pichia pastoris and Spodoptera frugiperda. Analytical Biochemistry 543: 62–70.
Buchetics M, Dragosits M, Maurer M, Rebnegger C, Porro D, Sauer M, Gasser B,
Mattanovich D. 2011. Reverse engineering of protein secretion by uncoupling of cell cycle phases from growth. Biotechnology and Bioengineering 108: 2403–2412.
Buckland B, Boulanger R, Fino M, Srivastava I, Holtz K, Khramtsov N, McPherson C, Meghrous J, Kubera P, Cox MMJ. 2014. Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process.
Vaccine 32: 5496–5502.
Butler M. 2013. Serum-free media: standardizing cell culture system. Pharmaceutical Bioprocessing 1: 315–318.
Cereghino JL, Cregg JM. 2000. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiology Reviews 24: 45–66.
Contreras-Gómez A, Sánchez-Mirón A, García-Camacho F, Molina-Grima E, Chisti Y. 2014.
Protein production using the baculovirus-insect cell expression system.
Biotechnology Progress 30: 1–18.
Cox MMJ. 2012. Recombinant protein vaccines produced in insect cells. Vaccine 30:
1759–1766.
Cregg JM, Tolstorukov I, Kusari A, Sunga J, Madden K, Chappell T. 2009. Chapter 13 Expression in the Yeast Pichia pastoris. I: Burgess RR, Deutscher MP (red.).
Methods in Enzymology, s. 169–189. Academic Press,
Cunningham LW. 1954. Molecular-kinetic properties of crystalline diisopropyl phosphoryl trypsin. The Journal of Biological Chemistry 211: 13–19.
Dada OO, Zhao Y, Jaya N, Salas-Solano O. 2017. High-Resolution Capillary Zone
Electrophoresis with Mass Spectrometry Peptide Mapping of Therapeutic Proteins:
Peptide Recovery and Post-translational Modification Analysis in Monoclonal Antibodies and Antibody–Drug Conjugates. Analytical Chemistry 89: 11236–11242.
Darby RAJ, Cartwright SP, Dilworth MV, Bill RM. 2012. Which yeast species shall I choose?
Saccharomyces cerevisiae versus Pichia pastoris (review). Methods in Molecular Biology (Clifton, NJ) 866: 11–23.
Dhara VG, Naik HM, Majewska NI, Betenbaugh MJ. 2018. Recombinant Antibody
Production in CHO and NS0 Cells: Differences and Similarities. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 32: 571–584.
Drugbank, 2012. Ocriplasmin. WWW-dokument: https://www.drugbank.ca/drugs/DB08888.
Hämtad 2020-05-26.
Drugbank. Hemmagglutinin WWW-dokument:
https://www.drugbank.ca/polypeptides/P03437. Hämtad 2020-06-01.
Drugmand J-C, Schneider Y-J, Agathos SN. 2012. Insect cells as factories for biomanufacturing. Biotechnology Advances 30: 1140–1157.
Dumont J, Euwart D, Mei B, Estes S, Kshirsagar R. 2016. Human cell lines for
biopharmaceutical manufacturing: history, status, and future perspectives. Critical Reviews in Biotechnology 36: 1110–1122.
EMA. 2018a. Semglee. WWW-dokument 2018-09-17:
https://www.ema.europa.eu/en/medicines/human/EPAR/semglee. Hämtad 2020-05-26.
EMA. 2018b. Jetrea. WWW-dokument 2018-09-17:
https://www.ema.europa.eu/en/medicines/human/EPAR/jetrea. Hämtad 2020-05-26.
EMA. 2018c. Kalbitor: Withdrawn application. WWW-dokument 2018-09-17:
https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/kalbitor.
Hämtad 2020-05-26.
EMA. 2018d. Cervarix. WWW-dokument 2018-09-17:
https://www.ema.europa.eu/en/medicines/human/EPAR/cervarix. Hämtad 2020-06-01.
Felberbaum RS. 2015. The baculovirus expression vector system: A commercial
manufacturing platform for viral vaccines and gene therapy vectors. Biotechnology Journal 10: 702–714.
Food and Drug administration. Package Insert - Flublok Quadrivalent WWW-dokument 2019-11: https://www.fda.gov/media/123144/download. Hämtad 2020-05-31.
Friedman M, Ståhl S. 2009. Engineered affinity proteins for tumour-targeting applications.
Biotechnology and Applied Biochemistry 53: 1–29.
Gibco. Growth and maintenance of insect cell lines WWW-dokument:
http://tools.thermofisher.com/content/sfs/manuals/Insect_Cell_Lines_UG.pdf. Hämtad 2020-06-01.
Gómez-Sebastián S, López-Vidal J, Escribano JM. 2014. Significant Productivity
Improvement of the Baculovirus Expression Vector System by Engineering a Novel Expression Cassette. PLoS ONE, doi 10.1371/journal.pone.0096562.
Goncalves AM. 2013. Pichia pastoris: A Recombinant Microfactory for Antibodies and Human Membrane Proteins. Journal of Microbiology and Biotechnology 23: 587–601.
Jarvis DL. 2009. Chapter 14 Baculovirus–Insect Cell Expression Systems. Methods in Enzymology, s. 191–222. Elsevier,
Joyce JG, Tung J-S, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM. 1999. The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface
Glycosaminoglycans on Human Keratinocytes. Journal of Biological Chemistry 274:
5810–5822.
Junne S, Neubauer P. 2018. How scalable and suitable are single-use bioreactors? Current Opinion in Biotechnology 53: 240–247.
Juturu V, Wu JC. 2018. Heterologous Protein Expression in Pichia pastoris: Latest Research Progress and Applications. ChemBioChem 19: 7–21.
Kenanova VE, Olafsen T, Salazar FB, Williams LE, Knowles S, Wu AM. 2010. Tuning the serum persistence of human serum albumin domain III:diabody fusion proteins.
Protein Engineering, Design and Selection 23: 789–798.
Kim JY, Kim Y-G, Lee GM. 2012. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Applied Microbiology and Biotechnology 93: 917–930.
Kobayashi K, Kuwae S, Ohya T, Ohda T, Ohyama M, Tomomitsu K. 2000. High level secretion of recombinant human serum albumin by fed-batch fermentation of the
methylotrophic yeast, Pichia pastoris, based on optimal methanol feeding strategy.
Journal of Bioscience and Bioengineering 90: 280–288.
Kost TA, Kemp CW. 2016. Fundamentals of Baculovirus Expression and Applications. I:
Vega MC (red.). Advanced Technologies for Protein Complex Production and Characterization, s. 187–197. Springer International Publishing, Cham.
Kunert R, Reinhart D. 2016. Advances in recombinant antibody manufacturing. Applied Microbiology and Biotechnology 100: 3451–3461.
Lebozec K, Jandrot-Perrus M, Avenard G, Favre-Bulle O, Billiald P. 2018. Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development. New Biotechnology 44: 31–40.
Lebozec K, Jandrot-Perrus M, Avenard G, Favre-Bulle O, Billiald P. 2017. Design,
development and characterization of ACT017, a humanized Fab that blocks platelet’s glycoprotein VI function without causing bleeding risks. mAbs 9: 945–958.
Liu W-C, Gong T, Wang Q-H, Liang X, Chen J-J, Zhu P. 2016. Scaling-up Fermentation of Pichia pastoris to demonstration-scale using new methanol-feeding strategy and increased air pressure instead of pure oxygen supplement. Scientific Reports 6:
18439.
Liu X, Chen Y, Zhao Y, Liu-Compton V, Chen W, Payne G, Lazar AC. 2019. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process. Journal of Pharmaceutical and Biomedical Analysis 174:
500–508.
Liu X, Yang Y, Zhang W, Sun Y, Peng F, Jeffrey L, Harvey L, McNeil B, Bai Z. 2016.
Expression of recombinant protein using Corynebacterium Glutamicum: progress, challenges and applications. Critical Reviews in Biotechnology 36: 652–664.
Looser V, Bruhlmann B, Bumbak F, Stenger C, Costa M, Camattari A, Fotiadis D, Kovar K.
2015. Cultivation strategies to enhance productivity of Pichia pastoris: A review.
Biotechnology Advances 33: 1177–1193.
López-Vidal J, Gómez-Sebastián S, Bárcena J, Nuñez M del C, Martínez-Alonso D, Dudognon B, Guijarro E, Escribano JM. 2015. Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System. PLoS ONE, doi 10.1371/journal.pone.0140039.
López-Vidal J, Gómez-Sebastián S, Sánchez-Ramos I, Escribano JM. 2013.
Characterization of a Trichoplusia ni hexamerin-derived promoter in the AcMNPV baculovirus vector. Journal of Biotechnology 165: 201–208.
Maccani A, Landes N, Stadlmayr G, Maresch D, Leitner C, Maurer M, Gasser B, Ernst W, Kunert R, Mattanovich D. 2014. Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteins. Biotechnology Journal 9: 526–537.
Magalhães P, Lopes A, Mazzola P, Rangel-Yagui C, Penna T, Pessoa A. 2007. Methods of endotoxin removal from biological preparations: A review. Journal of pharmacy &
pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 10: 388–404.
Martínez-Solís M, Herrero S, Targovnik AM. 2019. Engineering of the baculovirus expression system for optimized protein production. Applied Microbiology and Biotechnology 103: 113–123.
Meyer V, Basenko EY, Benz JP, Braus GH, Caddick MX, Csukai M, de Vries RP, Endy D, Frisvad JC, Gunde-Cimerman N, Haarmann T, Hadar Y, Hansen K, Johnson RI, Keller NP, Kraševec N, Mortensen UH, Perez R, Ram AFJ, Record E, Ross P, Shapaval V, Steiniger C, van den Brink H, van Munster J, Yarden O, Wösten HAB.
2020. Growing a circular economy with fungal biotechnology: a white paper. Fungal Biology and Biotechnology 7: 5.
Noh SM, Shin S, Lee GM. 2018. Comprehensive characterization of glutamine
synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies. Scientific Reports 8: 5361.
Palomares LA, Realpe M, Ramírez OT. 2015. An Overview of Cell Culture Engineering for the Insect Cell-Baculovirus Expression Vector System (BEVS). I: Al-Rubeai M (red.).
Animal Cell Culture, s. 501–519. Springer International Publishing, Cham.
Pereira S, Kildegaard HF, Andersen MR. 2018. Impact of CHO Metabolism on Cell Growth and Protein Production: An Overview of Toxic and Inhibiting Metabolites and Nutrients. Biotechnology Journal 13: 1700499.
Portolano N, Watson PJ, Fairall L, Millard CJ, Milano CP, Song Y, Cowley SM, Schwabe JWR. 2014. Recombinant protein expression for structural biology in HEK 293F suspension cells: a novel and accessible approach. Journal of Visualized Experiments: JoVE e51897.
PubChem. Insulin glargine. WWW-dokument:
https://pubchem.ncbi.nlm.nih.gov/compound/118984454. Hämtad 2020-05-26.
Rantasalo A, Vitikainen M, Paasikallio T, Jäntti J, Landowski CP, Mojzita D. 2019. Novel genetic tools that enable highly pure protein production in Trichoderma reesei.
Scientific Reports 9: 5032.
Rebnegger C, Graf AB, Valli M, Steiger MG, Gasser B, Maurer M, Mattanovich D. 2014. In Pichia pastoris, growth rate regulates protein synthesis and secretion, mating and stress response. Biotechnology Journal 9: 511–525.
Reinhart D, Damjanovic L, Kaisermayer C, Sommeregger W, Gili A, Gasselhuber B, Castan A, Mayrhofer P, Grünwald-Gruber C, Kunert R. 2019. Bioprocessing of Recombinant CHO-K1, CHO-DG44, and CHO-S: CHO Expression Hosts Favor Either mAb
Production or Biomass Synthesis. Biotechnology Journal 14: e1700686.
Ritacco FV, Wu Y, Khetan A. 2018. Cell culture media for recombinant protein expression in Chinese hamster ovary (CHO) cells: History, key components, and optimization
strategies. Biotechnology Progress 34: 1407–1426.
Roldão A, Vicente T, Peixoto C, Carrondo MJT, Alves PM. 2011. Quality control and
analytical methods for baculovirus-based products. Journal of Invertebrate Pathology 107: S94–S105.
Romanova N, Noll T. 2018. Engineered and Natural Promoters and Chromatin-Modifying Elements for Recombinant Protein Expression in CHO Cells. Biotechnology Journal 13: 1700232.
Schmidt FR. 2004. Recombinant expression systems in the pharmaceutical industry. Applied Microbiology and Biotechnology 65: 363–372.
Sigma Aldrich. Protein Expression Systems. WWW-dokument:
https://www.sigmaaldrich.com/technical-documents/articles/biology/protein-expressio n-systems.html. Hämtad 2020-05-29.
Ståhl S, Gräslund T, Eriksson Karlström A, Frejd FY, Nygren P-Å, Löfblom J. 2017. Affibody Molecules in Biotechnological and Medical Applications. Trends in Biotechnology 35:
691–712.
Taguchi S, Ooi T, Mizuno K, Matsusaki H. 2015. Advances and needs for endotoxin-free production strains. Applied Microbiology and Biotechnology 99: 9349–9360.
Tran A-M, Nguyen T-T, Nguyen C-T, Huynh-Thi X-M, Nguyen C-T, Trinh M-T, Tran L-T, Cartwright SP, Bill RM, Tran-Van H. 2017. Pichia pastoris versus Saccharomyces cerevisiae: a case study on the recombinant production of human
granulocyte-macrophage colony-stimulating factor. BMC Research Notes 10: 1–8.
Tripathi NK, Shrivastava A. 2019. Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development. Frontiers in Bioengineering and Biotechnology 7: 420.
van Oers MM. 2011. Opportunities and challenges for the baculovirus expression system.
Journal of Invertebrate Pathology 107: S3–S15.
van Oers MM, Lynn DE. 2010. Insect Cell Culture. I: John Wiley & Sons, Ltd (red.).
Encyclopedia of Life Sciences, s. a0002574.pub2. John Wiley & Sons, Ltd, Chichester, UK.
Vogl T, Hartner FS, Glieder A. 2013. New opportunities by synthetic biology for
biopharmaceutical production in Pichia pastoris. Current Opinion in Biotechnology 24:
1094–1101.
Walsh G. 2018. Biopharmaceutical benchmarks 2018. Nature Biotechnology 36: 1136–1145.
Wang X-Y, Yi D-D, Wang T-Y, Wu Y-F, Chai Y-R, Xu D-H, Zhao C-P, Song C. 2019.
Enhancing expression level and stability of transgene mediated by episomal vector via buffering DNA methyltransferase in transfected CHO cells. Journal of Cellular Biochemistry 120: 15661–15670.
Wolverton SE, Wu JJ. 2019. Comprehensive Dermatologic Drug Therapy E-Book. Elsevier Health Sciences
You M, Yang Y, Zhong C, Chen F, Wang X, Jia T, Chen Y, Zhou B, Mi Q, Zhao Q, An Z, Luo W, Xia N. 2018. Efficient mAb production in CHO cells with optimized signal peptide, codon, and UTR. Applied Microbiology and Biotechnology 102: 5953–5964.
Zboray K, Sommeregger W, Bogner E, Gili A, Sterovsky T, Fauland K, Grabner B, Stiedl P, Moll HP, Bauer A, Kunert R, Casanova E. 2015. Heterologous protein production using euchromatin-containing expression vectors in mammalian cells. Nucleic Acids Research 43: e102.